Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Pfizer
Pfizer
Hoffmann-La Roche
University of Virginia
Bayer
Bristol-Myers Squibb
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
Columbia University
Vanderbilt-Ingram Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Rutgers, The State University of New Jersey
University of South Florida
Vanderbilt University